On March 18, 2021, the North DuSable Lake Shore Drive project team held Task Force (TF) Committee Meeting #12 virtually through the online webinar platform, Zoom. This format was used to respect current public health and safety guidance related to the COVID-19 pandemic. Task Force committee members were invited to attend one of two identical one and a half hour sessions. The first session was held from 9 a.m. to 10:30 a.m.; the second session was held from 1 p.m. to 2:30 p.m. Representatives from the Corridor Planning Committee and all Task Force Groups were in attendance. Participants included several new Task Force committee members that applied during the Fall 2020 Public Input Opportunity.
The meeting began with a recap of the Level 2 Screening process recommendations and highlighted the five Alternatives identified to be carried forward:
- The Essential (formerly known as Context Tailored Treatment Plus Transit Advantage (CTT+TA))
- The Addition (formerly known as Dedicated Transitway-Left (DTW-L))
- The Exchange (formerly known as 3+1 Bus Only Lane (3+1 BOL))
- The Flex (formerly known as the 3+1 Managed Lane (3+1 ML))
- The Double Flex (formerly known as the 2+2 Managed Lane (2+2 ML))
The project team proceeded to review the Public Input Opportunity, including the meeting format, the input received through various engagement tools, and the key themes heard including the Lakefront Trail, parks and park access, transit, and tolling. The project team also discussed the anticipated community outreach activities scheduled to take place in 2021, including Northern Terminus Traffic Study (NTTS) Community Meetings and a Lakeview Community Meeting.
The project team then discussed the upcoming Level 3 Screening process that will evaluate and analyze the five remaining alternatives relative to each other using criteria in four categories: performance, social, economic, and environmental. The Preferred Alternative will be selected based upon the results of the Level 3 analysis, consideration of public input, and compliance with federal reviews. The meeting concluded with the project team providing the anticipated Level 3 Screening schedule and the study’s overall next steps.
This Task Force committee meeting also included an opportunity for active participation with attendees encouraged to submit questions using the Zoom chat function or verbally. There were five designated question-and-answer periods during the presentation during which to the project team directly responded to Task Force members’ questions.
In total, there were 84 Task Force committee members who attended, as follows:
- Morning Session – 39
- Afternoon Session – 45
Comments and feedback from Task Force committee members will be collected through Friday, April 9.